Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

Jonathan Emberson(University of Oxford), Werner Hacke(Heidelberg University), Erich Bluhmki(Boehringer Ingelheim (Germany)), Gordon Murray(Nova Scotia Department of Agriculture), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Gregory W. Albers(Stanford University), James C. Grotta(Memorial Hermann), Peter Sandercock(University College London), Colin Baigent(University of Oxford), Geoffrey A. Donnan(The Royal Melbourne Hospital), Masatoshi Koga(National Cerebral and Cardiovascular Center), Barbara C. Tilley(The University of Texas Health Science Center at Houston), William Whiteley(University of Edinburgh), Lisa Blackwell(University of Oxford), Danilo Toni(Sapienza University of Rome), Richard I. Lindley(Westmead Hospital), Markku Kaste(University of Helsinki), Jean‐Marc Olivot(Stanford University), Nils Wahlgren(Karolinska Institutet), Mark Parsons(UNSW Sydney), Patrick D. Lyden(Keck Hospital of USC), George Howard(University of Alabama at Birmingham), Stephen C. Davis(University of Melbourne), Kennedy R. Lees(University of Graz), Gregory J. del Zoppo(University of Washington), Geoff Cohen(University of Edinburgh), Ruediger von Kummer(TU Dresden), Maarten G. Lansberg(Stanford University), Thomas Brott(WinnMed), Joanna M. Wardlaw(University of Edinburgh)
The Lancet
August 5, 2014
Cited by 2,719


Related Papers